Clinical Trial Update: A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2304T and AG2304R [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is planned to evaluate the efficacy and safety of AG2304T and AG2304R for hypercholesterolemia; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• AG2304R
• AG2304T

Snippet

Sponsor: Ahn-Gook Pharmaceuticals Co.,Ltd | Conditions: Hypercholesterolemia | Phase 3 | Status: NOT_YET_RECRUITING